Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Phase I/II Trial of Endometrial Regenerative Cells (ERC) in Patients With Critical Limb Ischemia
This study is not yet open for participant recruitment.
Verified March 2012
by Medistem Inc.
Study NCT01558908 Information provided by Medistem Inc.
First Received on March 18, 2012. No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Peripheral Vascular Diseases
Additional conditions recognized in this trial
Peripheral Arterial Disease
More general conditions related to this trial
Arterial Occlusive Diseases
Neoplasms by Histologic Type
Neoplasms, Glandular and Epithelial
Interventions listed in this trial
Administration of ERC
Sponsors listed in this trial
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers